Our previous studies indicated that USP24 promotes drug resistance during cancer therapy and leads to the development of a novel USP24‐specific small‐molecule inhibitor, NCI677397, to suppress drug resistance, especially in lung cancer [14]. The gene discussed is USP24; the disease is lung carcinoma.